ABI-5366

N/A

Report date: 2024/06/28 15:24:31
NME

Base Information

Drug NameABI-5366
Drug Alias NameLong Acting HPIs (Assembly Biosciences)ABI-5366
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA helicase/primase complex inhibitors
TargetsDNA helicase/primase complex
Therapy Area/IndicationsHerpes SimplexHerpes Genitalis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAssembly Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences IncAssembly Biosciences Inc
Inactive CompaniesN/A
Active IndicationsHerpes SimplexHerpes Genitalis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A